Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-25 @ 5:59 AM
Study NCT ID:
NCT02588456
Status:
TERMINATED
Last Update Posted:
2023-06-22
First Post:
2015-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia
Sponsor:
University of Pennsylvania
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UPCC 31415, 822967
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None